Amundi MSCI World Ex USA UCITS ETF Acc is a equity ETF from Amundi tracking the MSCI World Ex USA index through physical replication. Domiciled in Ireland and launched in 2024, the fund manages about 626 M € and charges a TER of 0.15% — 15 € per year on a €10,000 investment. Income is automatically reinvested in the fund (accumulating).
Amundi MSCI World Ex USA UCITS ETF Acc competes with 359 other products in the same class and region (Equity, USA): it ranks 145th by fund size and 120th by ongoing cost, with a TER of 0.15% against a group median of 0.20%. It has been listed since 2024, 2 years of track record.
On a €10,000 investment the TER costs 15 € a year, against 20 € for the median product in the category.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 13.1% of the portfolio.
Income is accumulated: no distribution is paid out, the share price absorbs it. In a savings plan this removes the need to reinvest dividends by hand. The fund is denominated in EUR. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
Irish domicile lets the fund apply the Ireland–US tax treaty, with 15% withholding instead of 30% on US dividends received by the fund.
| ASML Holding N.V. | 3.1% |
| HSBC Holdings PLC | 1.3% |
| Royal Bank of Canada | 1.2% |
| Roche Holding AG | 1.2% |
| Novartis AG | 1.2% |
| AstraZeneca PLC | 1.2% |
| Nestle S.A. | 1.1% |
| Siemens Aktiengesellschaft | 1.0% |
| Shell plc | 0.9% |
| Tokyo Electron Limited | 0.9% |
| XETRA | WEXE | EUR |
| London Stock Exchange | WEXU | GBP |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.